Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2020 12 Junio 2020 News Human Pharmacovigilance Referrals Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic 9 Junio 2020 Press release Human COVID-19 Medicines Research and development EU actions to support availability of medicines during COVID-19 pandemic – update #7 8 Junio 2020 Press release Human Veterinary COVID-19 Medicine shortages EMA receives application for conditional authorisation of first COVID-19 treatment in the EU 8 Junio 2020 Press release Human COVID-19 Medicines Patients’ and healthcare professionals’ organisations updated on EMA’s response to COVID-19 4 Junio 2020 News Human COVID-19 COVID-19: reminder of the risks of chloroquine and hydroxychloroquine 29 Mayo 2020 Press release Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 May 2020 29 Mayo 2020 News Human COVID-19 Biosimilars Generic and hybrid medicines Medicines New vaccine for prevention of Ebola virus disease recommended for approval in the European Union 29 Mayo 2020 Press release Human Medicines Vaccines Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3 28 Mayo 2020 Press release Human Clinical trials Medicine shortages Quality of medicines Essential work to combat the COVID-19 pandemic to continue during EMA's closure on 1 June 2020 28 Mayo 2020 News Corporate COVID-19 1 … 80 81 82 83 84 Page 84 of 380 85 86 87 88 … 380
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2020 12 Junio 2020 News Human Pharmacovigilance Referrals
Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic 9 Junio 2020 Press release Human COVID-19 Medicines Research and development
EU actions to support availability of medicines during COVID-19 pandemic – update #7 8 Junio 2020 Press release Human Veterinary COVID-19 Medicine shortages
EMA receives application for conditional authorisation of first COVID-19 treatment in the EU 8 Junio 2020 Press release Human COVID-19 Medicines
Patients’ and healthcare professionals’ organisations updated on EMA’s response to COVID-19 4 Junio 2020 News Human COVID-19
COVID-19: reminder of the risks of chloroquine and hydroxychloroquine 29 Mayo 2020 Press release Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 May 2020 29 Mayo 2020 News Human COVID-19 Biosimilars Generic and hybrid medicines Medicines
New vaccine for prevention of Ebola virus disease recommended for approval in the European Union 29 Mayo 2020 Press release Human Medicines Vaccines
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3 28 Mayo 2020 Press release Human Clinical trials Medicine shortages Quality of medicines
Essential work to combat the COVID-19 pandemic to continue during EMA's closure on 1 June 2020 28 Mayo 2020 News Corporate COVID-19